CLOPIDOGREL BISULFATE
Generic: CLOPIDOGREL BISULFATE
Rising Pharma HoldingsManufacturer
ORALRoute
CLOPIDOGREL BISULFATEActive Substance
2017-02-02Original Approval
CLOPIDOGREL BISULFATE is FDA application ANDA204359, sponsored by RISING. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2021-08-02
Clopidogrel Tablets, USP, 75 mg, 500-count bottle, Rx only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ Presence of foreign matter
Class II2018-11-07
Clopidogrel Tablets, USP, 300 mg, 30 (5 x 6 unit-dose) count blister pack, Rx only, Manufactured by Dr. Reddy's LaboratoFailed Dissolution Specification: Out-of-Specification results were observed for dissolution at 18th
Class II2018-12-10
Clopidogrel Tablets, USP, 300 mg, 30 (5 x 6 unit-dose) count blister pack, Rx only, Manufactured by Dr. Reddy's LaboratoFailed dissolution specification -Two additional lots being recalled due to Out-of-Specification res
Top Reported Reactions
1
DYSPNOEA
5,469 reports
2
FATIGUE
4,848 reports
3
DIZZINESS
4,257 reports
4
DIARRHOEA
4,158 reports
5
DRUG INEFFECTIVE
4,135 reports
6
NAUSEA
3,953 reports
7
ANAEMIA
3,798 reports
8
DRUG INTERACTION
3,692 reports
9
FALL
3,660 reports
10
MYOCARDIAL INFARCTION
3,508 reports